| Style | Citing Format |
|---|---|
| MLA | Mansori K, Ayubi E, Safiri S. "Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”." Brachytherapy, vol. 17, no. 2, 2018, pp. 514-515. |
| APA | Mansori K, Ayubi E, Safiri S (2018). Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”. Brachytherapy, 17(2), 514-515. |
| Chicago | Mansori K, Ayubi E, Safiri S. "Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”." Brachytherapy 17, no. 2 (2018): 514-515. |
| Harvard | Mansori K, Ayubi E, Safiri S (2018) 'Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”', Brachytherapy, 17(2), pp. 514-515. |
| Vancouver | Mansori K, Ayubi E, Safiri S. Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”. Brachytherapy. 2018;17(2):514-515. |
| BibTex | @article{ author = {Mansori K and Ayubi E and Safiri S}, title = {Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival”}, journal = {Brachytherapy}, volume = {17}, number = {2}, pages = {514-515}, year = {2018} } |
| RIS | TY - JOUR AU - Mansori K AU - Ayubi E AU - Safiri S TI - Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival” JO - Brachytherapy VL - 17 IS - 2 SP - 514 EP - 515 PY - 2018 ER - |